STOCK TITAN
  1. Home
  2. Sec-filings
  3. CL
  4. [Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

CL Form 4: CFO Receives RSUs and Long-Dated Options with $84.06 Strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Colgate-Palmolive's chief financial officer received equity awards from the company as disclosed on a Section 16 filing. The filing shows a grant of 8,328 restricted stock units and a stock option for 57,661 underlying shares with an exercise price of $84.06 and an expiration in 2033. After the reported transactions the reporting person beneficially owned 57,732 shares directly and held 324 shares indirectly through the issuer's 401(k) plan trustee. The restricted stock units vest in three equal annual installments and the option vests in equal annual installments over three years.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: A routine, multi-year equity grant to the CFO aligns management incentives with shareholders without immediate dilution from exercised options.

The awards combine restricted stock units and a long-dated option, creating both retention value and potential upside exposure tied to future share price performance. The option strike of $84.06 and eight-year term provide time for value realization, while graded vesting over three years encourages retention. The direct ownership of 57,732 shares plus 401(k) holdings modestly increases insider alignment but does not represent a material change in ownership percentage.

TL;DR: Grant structure is standard for senior executives: time-based vesting and a mix of RSUs and options to balance retention and performance.

The RSUs vest in equal annual installments over three years and the option vests similarly, which is consistent with common governance practices to promote medium-term alignment. There is no disclosure of performance conditions or accelerated vesting triggers in this filing. The transaction appears to be a standard compensation grant rather than an opportunistic purchase or sale by the officer.

Insider SUTULA STANLEY J III
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 57,661 $0.00 --
Grant/Award Common Stock 8,328 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 57,661 shares (Direct); Common Stock — 57,732 shares (Direct); Common Stock — 324 shares (Indirect, By Issuer's 401(k) Plan Trustee)
Footnotes (1)
  1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant. Stock option award granted under the issuer's incentive compensation plan. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SUTULA STANLEY J III
(Last) (First) (Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NY 10022
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/11/2025 A(1) 8,328 A $0.0000 57,732 D
Common Stock 324 I By Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $84.06 09/11/2025 A(2) 57,661 (3) 09/11/2033 Common Stock 57,661 $0.0000 57,661 D
Explanation of Responses:
1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
2. Stock option award granted under the issuer's incentive compensation plan.
3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact 09/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Colgate-Palmolive CFO receive in the Form 4 filing?

The CFO received 8,328 restricted stock units and a stock option covering 57,661 underlying shares with an exercise price of $84.06.

How many shares does the reporting person own after the reported transactions for CL?

Following the reported transactions the reporting person beneficially owned 57,732 shares directly and held 324 shares indirectly via the company's 401(k) plan trustee.

What are the vesting and exercisability terms for the awarded securities?

The restricted stock units vest in three equal annual installments; the option becomes exercisable in equal annual installments over three years beginning one year after the grant.

What is the exercise price and expiration date of the stock option reported?

The reported stock option has an exercise price of $84.06 and an expiration date in 2033.

Was this Form 4 filing a purchase or a grant?

The filing reports an A transaction code for acquisition; the explanations state these were awards granted under the issuer's incentive compensation plan (RSUs and a stock option).